IFIH1 and systemic lupus erythematosus: In that case, PLA2R antibody-positive disease will be defined as a syndrome in its own right outside lupus and IFIH1 mutation-positive disease will be classified under the MDA5 syndrome not associated with either dermatomyositis or SLE.